Jubilant Pharmova Balance Sheet Health
Financial Health criteria checks 3/6
Jubilant Pharmova has a total shareholder equity of ₹54.0B and total debt of ₹36.7B, which brings its debt-to-equity ratio to 67.9%. Its total assets and total liabilities are ₹114.0B and ₹60.0B respectively. Jubilant Pharmova's EBIT is ₹4.5B making its interest coverage ratio 2. It has cash and short-term investments of ₹9.7B.
Key information
67.9%
Debt to equity ratio
₹36.68b
Debt
Interest coverage ratio | 2x |
Cash | ₹9.74b |
Equity | ₹54.01b |
Total liabilities | ₹59.98b |
Total assets | ₹114.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530019's short term assets (₹36.1B) exceed its short term liabilities (₹17.9B).
Long Term Liabilities: 530019's short term assets (₹36.1B) do not cover its long term liabilities (₹42.1B).
Debt to Equity History and Analysis
Debt Level: 530019's net debt to equity ratio (49.9%) is considered high.
Reducing Debt: 530019's debt to equity ratio has reduced from 84.7% to 67.9% over the past 5 years.
Debt Coverage: 530019's debt is well covered by operating cash flow (26.8%).
Interest Coverage: 530019's interest payments on its debt are not well covered by EBIT (2x coverage).